Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
Open | $1.13 |
Close | $1.11 |
Volume / Avg. | 93.00K / 525.75K |
Day Range | $1.09 - $1.15 |
52 Wk Range | 0.68 - 4.10 |
Market Cap | $78.78M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 1.23% |
Days to Cover | 3.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Other companies in Ovid Therapeutics’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB) and Armata Pharmaceuticals (AMEX:ARMP).
Ovid Therapeutics has a consensus price target of $4.74.
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $1.11 last updated September 23, 2024 at 4:02 PM EDT.
There are no upcoming dividends for Ovid Therapeutics.
Ovid Therapeutics’s Q3 earnings are confirmed for Friday, November 1, 2024.
There is no upcoming split for Ovid Therapeutics.
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.